2Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量:1931
7Wiegand J, Tischendorf J J, Nashan B, et al. Severe exacerbation of chronic hepatitis B after emergence of lamivudine resistance in a cirrhotic patient: Immediate switch to adefovir dipivoxil appears to be indicated [ J ]. Z Gastroenterol, 2004, 42( 1 ) :15-18.
8Zhang JM, Wang XY, Huang YX, et al. Fatal liver failure with the emergence of hepatitis B surface antigen variants with multiple stop mutations after discontinuation of lamivudine therapy [ J ]. J Med Virol, 2006, 78 (3):324-328.
9Lin PC, Poh SB, Lee MY, et al. Fatal fulminant hepatitis B after withdrawal of prophylactic lamivudine in hematopoietic stem cell transplantation patients [ J]. Int J Hematol, 2005, 81(4):349-351.
10Ratziu V, Thibauh V, Benhamou Y, et al. Successful rescue therapy with tenofovir in a patient with hepatic decompensation and adefovir resistant HBV mutant [ J ]. Comp Hepatol, 2006, 5:1-4.
3Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646. 被引量:830